Journal article icon

Journal article

Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.

Abstract:

BACKGROUND: The safety and efficacy of paliperidone extended-release tablets (paliperidone ER) in patients with acute symptoms of schizophrenia have been described in 3 randomized, double-blind, 6-week, placebo-controlled, fixed-dose, Phase III clinical trials. The validity and reliability of the Personal and Social Performance (PSP) scale, both in patients with acute symptoms of schizophrenia and those with stabilized symptoms, have also been reported. OBJECTIVE: The aim of this work was to...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Patrick, DL More by this author
Morosini, P More by this author
Gagnon, DD More by this author
Rothman, M More by this author
Expand authors...
Journal:
Clinical therapeutics
Volume:
32
Issue:
2
Pages:
275-292
Publication date:
2010-02-05
DOI:
EISSN:
1879-114X
ISSN:
0149-2918
URN:
uuid:3a3de9f0-f727-4a74-a257-7efdc581d38e
Source identifiers:
176753
Local pid:
pubs:176753

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP